Company intelligence / Profile preview

Asahi Kasei Ventures

Menlo Park, California, United States

Ownership: Private
Development stage: Other

Overview

Asahi Kasei Ventures is a corporate venture capital arm of Asahi Kasei focused on strategic equity investments in early-stage, innovative biopharmaceutical and multidisciplinary healthcare companies, primarily in immunology, kidney disease, neurodegeneration, rare disease, and related platforms. It does not develop its own therapeutics but backs multiple programs through its investments[1][3][9].

Therapeutic areas: NephrologyImmunologyNeurologyRare DiseasesOther
Modalities: Small moleculePeptidesNucleic acidCell therapyBiologic
Industry: Investors

Partnerships

Portfolio companies (e.g., Feldan Therapeutics, Hazel Technologies, Swing Therapeutics)Multiple early-stage biotech and healthcare startups

Beyond the preview

Go deeper on Asahi Kasei Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asahi Kasei Ventures.

Explore the full profile